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Pandoraea apista is newly described as a highly transmissible pathogen in CF 
causing respiratory deterioration. It may be misidentif ied as B. cepacia complex. 
Cobort isolation is recommended. Methods:  Sputum samples are grown on 
conventional media and B. cepacia selective medium (Mast Dia$paostics, United 
Kingdom). Fol lowing identification techniques are used: conventional pbenotypic 
tests, whole~cell fatty (CFA) analysis with Microbial identification System (MIS, 
Microbial ID, Newark, Del), DNA sequencing of the 16S rRNA gene mad SDS Page 
of whole cell proteins. Results:  A 20 yrs old CF male (E60X/AF508) with mild 
disease has Pseudornotw~s aeruginosa isolation since 1999, treated with col imycin 
aerosols. In 2004 S. aureus mad /~ aerugi~u~sa are cultured next to a rod shaped 
gram negative bacterium on a B. cepacia selective medium. Bicchemical and CFA 
analysis matches with PwMoraea species. Patuloraea apista is identified by 
comparison of its whole cell protein profile with those of references trains of a 
range of Gram negative non fermenting bacilli. Phenotyping and DNA sequencing 
of the 16S rRNA gene could not differentiate between PwMoraea apista and 
Pandoraea puImonicola. P tient is isolated. Discussion: Identification of new CF 
pathogens is chal lenging because of their differences in pathogenic potential and 
transmissibility. Identification may be problematic in routine laboratories, and 
increase workload of microbiology units. However B. cepacia showed the 
importance of correct identification ha a CF unit, to avoid spread. Mostly cl inical 
suspicion is impossible. Cobort isolation becomes complicated, and impossible 
without a qualif ied laboratory. 
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The last decade several Gram negative non fermenting bacil l i  (GN NFB ) other than 
Pseudomonas aeruginosa are newly described in CF, some as highly transmissible 
pathogens causing rapid respiratory deterioration. B. cepacia complex is best 
documented, however bloodstream infections are uncommon in CE The latter may 
be increasing as reported in hematology and intensive care units. Methods:  A total 
of 129 pediatric and adult patients are treated ha our center, 26.2% are colonized by 
1~ aeruginosa, B. cepacia is present ha only 4 patients. Sputum samples are grown 
on conventional media and B. cepacia selective medium (Mast Diagnostics, UK). 
Blood cultures are performed in patients with persisting fever or chills despite 
correct antibiotic treatment. Results:  A l l  blood cultures remained negative, except 
in 2 patients: a 29 yrs old male and a 27 yrs old female both on a lung 
transplantation wait ing list. Both were infected with B. cepacia, and had an 
intr avascular catheter. B. cepacia was cultured repeatedly from their blood samples. 
Moreover B. cepacia was isolated again ha one patient after removal of the infected 
catheter and replacement of a second long4erm catheter./~ aeruginosa was never 
recovered in any of the CF blood samples, even in patients with longstanding 
intravascular catheter and end stage respiratory failure. Discussion: GN NFB 
septicaemia may be increasing due to better identification techniques, older ages, 
aggressive treatment and the use of long4erm catheters. Mortal ity may be high. It 
is unclear why only GNNFB blood infections were seen in our series. 
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Objectives: The aim of this study was to evaluate whether Chlamydia pneumoniae 
might be involved in cases of adult patients with cystic fibrosis. 
Mater ia l s  mad methods: The studies were performed on 24 cystic fibrosis adults, 
aged 18 38 years and in control group, 15 patients (aged 19 42) alter acute upper 
airways infection. Fibreoptic bronchoscopy was performed in all patients and 
segmental bronchi samples of mucous membrane were taken. DNA was isolated 
from mucous membrane samples, using QIAamp DNA Min i  Kit (Qiagen). Presence 
of the isolated DNA was checked electr ophoretically. Chlamydia pneumoniae (147 
bp) sequence of DNA were detected using nested PCR amplif ication assay. 
Detection was carried out ha 2% agarose gels using ethidium bromide. 
Results: Chlamydia pneumoniae DNA was detected in 7 cystic fibrosis patients 
(29,2%) and in 2 patients from control group (13,3%). 
Conclusion: The results indicate that Chlamydia pneumoniae may be involved ha 
the clinical course of cystic fibrosis patients. 
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Objectives B.cepacia is considered a threatening pathogen for CF patients. In 
Greece, isolation frequency of B.cepacia among microorganisms causing serious 
respiratory infections in CF patients is considered extremely rare. We investigated 
the presence of B.cepacia in sputa of CF patients 
Methods The selective medium B. cepacia agar (Oxoid) was used, in addition to 
conventional media, for quantitatively culturing sputum samples of CF patients, 
admitted to our Hospital, for the period 2003 2CO4. Identification methods included 
API 20E, API NE, mad Vitek 2 (Biomerieux). Al l  Gram ( ) ,  oxidase (+) isolates were 
also screened initial ly by a multiplex PCR, in order to characterize the two bacterial 
species/~ aeruginosa and B. cepacia. The multiplex PCR included primers specific 
for the 520bp fragment of the aIgD GDP mamlose dehydrogenase gene of /~ 
aeruginosa, and the 463bp fragment of the ribosomal 16S gene, identify hag the f ive 
main gemovars of B. cepacia. Included in the mult iplex PCR was a tmiversal 
bacterial primer pair targeting the 16S rRNA to act as internal control (233bp). 
Samples giv ing results for the 520 and/or 463bp fragments were further tested for 
the identification of the bacterial strain with specific PCR. The recA gene PCR is a 
useful assay, which discriminates between the B. cepacia complex and B. cepacia 
l ike microorganisms. 
Results None of Gram negative isolates was identified as B. cepacia, either by 
using the selective B.cepacia medium or performing PCR. 
Conclusions There is strong evidence that B. cepacia participation in CF 
respiratory infections is rather unusual in Greece. 
